ReviewPathology, research and practice2025
Incidental early mixed epithelial and stromal tumor of the efferent testicular-ductular system of the genitourinary tract: A small case series with literature review.
Review in Pathology, research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mixed Epithelial Stromal Tumour of the Seminal Vesicle Presenting with Recurrent Acute Urinary Retention: A Case Report.Diagnostics (Basel, Switzerland) · 2026Article
- Malignant/Sarcomatous Transformation of Mixed Epithelial and Stromal Tumor of the Kidney: A Case Report.IJU case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Mixed epithelial and stromal tumors (MEST) are rare, hormone-driven tumors of the genitourinary tract composed of stromal and epithelial components. They are rarely encountered in men, and it is exceedingly rare to find MESTs in efferent testicular-ductular structures. The current literature focuses on symptomatic men with macroscopically evident tumors. However, MESTs may present as incidental microscopic lesions and can easily be missed by the interpreting pathologist. Here, we discuss four cases of incidental low-grade MESTs of the seminal vesicle, ejaculatory duct, and epididymis. The patients were men ranged in age from 52 to 69 years old. Three were asymptomatic with elevated prostate specific antigen who were diagnosed with prostatic adenocarcinoma on core biopsies. Subsequent prostatectomies revealed MESTs with two cases involving the seminal vesicles and one involving the ejaculatory duct. The fourth patient presented with a testicular mass and was found to have vasitis nodosa, sperm granulomas, and a MEST of the epididymis. All four tumors demonstrated nodules composed of a bland spindled stroma and variable amounts of dilated glands lined by bland cuboidal epithelium. Immunohistochemistry showed stromal positivity for ER, PR, AR (patchy), and WT1 while the epithelial component expressed pancytokeratin, CK7, GATA3, AR, and PAX8 (weak), consistent with MEST. Low-grade incidental MESTs are usually benign with excellent long-term outcomes, although they can recur if incompletely excised or undergo malignant transformation. While these lesions are rarely reported, it is important to recognize the characteristic morphology and immunoprofile of MESTs to avoid misidentification and mismanagement of these tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.